RecruitingNot ApplicableNCT04664686
Rate or Rhythm Control in CRT: the RHYTHMIC Study
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Enrollment
70 participants
Start Date
Oct 19, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
70 patients with heart failure, AF and CRT with BiV\<95% will be randomised to either AF ablation or AV node ablation. Evaluation at 6 months with echocardiography and clinical assessment.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria5
- Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule.
- QRS duration \>120ms on surface ECG, severe left ventricular systolic impairment (EF≤35%) and clinical symptoms of heart failure despite optimum medical therapy (NYHA class II-IV) at time of CRT implant or upgrade
- Successful CRT implant or upgrade including atrial lead
- Biventricular pacing percentage \<95% secondary to atrial fibrillation at least 3 months post implant or upgrade
- Clinically indicated for AV node ablation
Exclusion Criteria7
- Life expectancy \<1 year
- Presence of atrial or ventricular thrombus
- Permanent atrial fibrillation
- Mechanical aortic valve replacement
- Severe peripheral vascular disease
- Female participants who are pregnant, lactating or planning pregnancy during the course of the study.
- Participation in other studies with active treatment / investigational arm
Interventions
PROCEDUREAF catheter ablation
Isolation of all four pulmonary veins and additional lesions, considered indicated by the operator
PROCEDUREAV node ablation
AV node ablation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04664686
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations